LENZ Therapeutics cuts costs, changes CEO as VIZZ sales rise 50%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| (NASDAQ: LENZ) | Delayed: 3.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.21 | 52 Week High | $ | |||
| Open | $3.21 | 52 Week Low | $ | |||
| Day High | $3.21 | P/E | N/A | |||
| Day Low | $3.21 | EPS | $ | |||
| Volume | 3,750 | |||||
